No it hasn't - read the response (unfortunately its 130 pages long).
This is standard devils advocate approach. The ODAC is designed to find anything that the FDA or MSB may have missed in their extensive discussions to date. The briefing papers from FDA are a prompt to trigger the ODAC to be creative in their analysis. MSB have known about these questions for some time - that's how their submission is so comprehensive.
Anyone else buy in after todays dip/crash?, page-72
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |